Royalty Pharma plc (RPRX) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Royalty Pharma are Director Mario Germano Giuliani (7.80Mn shares), CEO And Chairman Of The Board Pablo G. Legorreta (1.54Mn shares), EVP & Vice Chairman Christopher Hite (658.51K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
1978 Sicaf Sif S.A. Gg 22,081,156 16 Sep, 2022
1978 Sicaf Sif S.A. - Gg Strategic Gg 21,426,170 22 Sep, 2022
Mario Germano Giuliani 7,802,819 27 Jun, 2023
Management Ltd Avara 2,477,520 03 Jan, 2024
Pablo G. Legorreta CEO And Chairman Of The Board 1,540,955 07 Nov, 2025
James F. Reddoch EVP & Chief Scientific Officer 820,800 30 Sep, 2022
Christopher Hite EVP & Vice Chairman 658,510 07 Nov, 2025
Rory B Riggs 320,099 22 Feb, 2024
Gregory Norden 194,848 11 Aug, 2025
Marshall Urist EVP And Research & Investments 167,398 09 Dec, 2025
Henry A Fernandez 123,524 30 Jun, 2025
George W. Lloyd EVP And Investments & Clo 110,000 21 Nov, 2025
Errol B Desouza 81,352 14 May, 2025
Bonnie L Bassler 72,165 30 Sep, 2025
Ted W Love 53,848 14 May, 2025
Catherine M. Engelbert 51,128 15 May, 2025
Terrance P. Coyne EVP & Cfo 47,260 03 Dec, 2025
David C Hodgson 33,328 14 May, 2025
Vlad Coric 10,798 14 May, 2025
Elizabeth H Weatherman 8,558 31 Jul, 2025
Carole Ho 8,558 31 Jul, 2025
William E Ford 6,597 30 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
05 Dec, 2025 Marshall Urist Class A Ordinary Shares D 23,334 $39.15 160,000 I S
05 Dec, 2025 Marshall Urist Class A Ordinary Shares D 18,242 $39.15 7,398 D S
03 Dec, 2025 George W. Lloyd Class A Ordinary Shares D 110,000 $39.77 110,000 I S
01 Dec, 2025 Marshall Urist Class A Ordinary Shares D 23,333 $39.93 183,334 I S
01 Dec, 2025 Terrance P. Coyne Class A Ordinary Shares D 65,832 $39.87 592,492 I S
01 Dec, 2025 Marshall Urist Class A Ordinary Shares D 18,242 $39.90 25,640 D S
01 Dec, 2025 Terrance P. Coyne Class A Ordinary Shares D 3,750 $39.87 47,260 I S
24 Nov, 2025 Terrance P. Coyne Class A Ordinary Shares D 55,146 $38.67 669,010 I S
24 Nov, 2025 Terrance P. Coyne Class A Ordinary Shares D 10,686 $37.96 658,324 I S
24 Nov, 2025 Terrance P. Coyne Class A Ordinary Shares D 3,126 $38.67 51,634 I S
24 Nov, 2025 Terrance P. Coyne Class A Ordinary Shares D 624 $37.96 51,010 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 47,798 $38.28 10,712 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 4,628 $39.01 6,084 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 47,401 $38.28 4,599 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 4,599 $39.01 0 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 25,530 $38.28 2,470 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 2,470 $39.01 0 I S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 2,770 $38.29 230 D S
19 Nov, 2025 George W. Lloyd Class A Ordinary Shares D 230 $39.03 0 D S
17 Nov, 2025 Terrance P. Coyne Class A Ordinary Shares D 65,844 $39.30 724,156 I S